Immunologically active biomaterials for cancer therapy

Current Topics in Microbiology and Immunology

Volumn 344, Issue 1, 2010, Pages 279-297

  Ali, Omar A ^a,b,c   Mooney, David J ^a  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c InCytu Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIBODY; ANTIGEN; BIOMATERIAL; CANCER VACCINE; CD11C ANTIBODY; CHITOSAN; COLLAGEN; CPG OLIGODEOXYNUCLEOTIDE; DEC 205 ANTIBODY; DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; LIPOSOME; NANOPARTICLE; OVALBUMIN; PLASMID DNA; POLY(ORTHO ESTER); POLYESTER; POLYETHYLENEIMINE; POLYGLACTIN; POLYGLYCOLIDE; POLYINOSINIC POLYCYTIDYLIC ACID; POLYLACTIDE; POLYPROPYLENE SULFIDE; POLYSACCHARIDE; RECOMBINANT GAMMA INTERFERON; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; IMMUNOLOGICAL ADJUVANT;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; ARTICLE; BLADDER TUMOR; CANCER IMMUNOTHERAPY; CONTROLLED DRUG RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG TARGETING; ENCAPSULATION; EXTRACELLULAR MATRIX; FOLLICULAR LYMPHOMA; IMMUNOREGULATION; MELANOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; T LYMPHOCYTE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASM; REVIEW;

ADJUVANTS, IMMUNOLOGIC; BIOCOMPATIBLE MATERIALS; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EID: 84862865591     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-69     Document Type: Article

References (89)

1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783-801 (Pubitemid 43261452)
2. Ali OA, Mooney DJ (2006) "Converging cell therapy with biomaterials". Cell transplantation from laboratory to clinic. Elsevier Inc., Burlington, MA, pp 591-609
3. Ali OA, Huebsch N, Cao L (2009a) Infection-mimicking materials to program dendritic cells in situ. Nat Mater 2:151-158
4. Ali OA, Emerich D, Dranoff G, Mooney DJ (2009b) In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci Transl Med 1:8-19
5. Audran R, Peter K, Dannull J et al (2003) Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Vaccine 21(11-12):1250-1255 (Pubitemid 36139957)
6. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 6673:245-252 (Pubitemid 28155090)
7. Banchereau J, Steinman RM (2007) Taking dendritic cells into medicine. Nature 49:419-426 (Pubitemid 47509552)
8. Bennewitz N, Babensee JE (2005) The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 26:2991-2999 (Pubitemid 39647234)
9. Bodnar M, Hartmann JF, Borbely J (2005) Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6(5):2521-2527 (Pubitemid 41388262)
10. Boontheekul T, Mooney DJ (2003) Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 14:559-565 (Pubitemid 37298044)
11. Borzacchiello A, Ambrosio L, Netti PA (2001) Chitosan-based hydrogels: synthesis and characterization. J Mater Sci Mater Med 12(10-12):861-864 (Pubitemid 34062102)
12. Brem H, Piantadosi S, Burger PC et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group. Lancet 345:1008-1012
13. Celluzzi CM, Mayordomo JI, Storkus WJ et al (1996) Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283-287 (Pubitemid 26028768)
14. Chevallay B, Herbage D (2000) Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med Biol Eng Comput 38(2):211-218 (Pubitemid 30192997)
15. Cohen JA, Neaudette TT, TsengWWet al (2009) T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem 20:111-119
16. Cubillos-Ruiz JR, Engle X, Scarlett UK et al (2009) Polyethylenimine- based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J Clin Invest 119(8):2231-2244
17. Curiel TJ, Curiel DT (2002) Tumor immunotherapy: inching toward the finish line. J Clin Invest 109:311-312 (Pubitemid 34141803)
18. Dibra A, Tiroch K, Schulz S et al (2010) Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol [Epub ahead of print]
19. Discher DE, Janmey P, Wang Y (2005) Tissue cells feel and respond to the stiffness of their substrate. Science 310(5751):1139-1143 (Pubitemid 41681732)
20. Discher DE, Mooney DJ, Zandstra PW (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324(5935):1673-1677
21. Doh J, Irvine DJ (1990) Immunological synapse arrays: patterned protein surfaces that modulate immunological synapse structure formation in T cells. Proc Natl Acad Sci USA 15:5700-5705
22. Eiselt P, Yeh J, Latvala RK et al (2000) Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials 21:1921-1927 (Pubitemid 30433820)
23. Elamanchili P, Lutsiak CME, Hamdy S et al (2007) Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells. J Immunother 30(4):378-395 (Pubitemid 46684428)
24. Gombotz WR, Pettit DK (1995) Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 6:332-351
25. Griffith LG (2002) Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann NY Acad Sci 961:83-95 (Pubitemid 34721746)
26. Gu F, Younes HM, El-Kadi AO et al (2005) Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer. J Control Release 102(3):607-617 (Pubitemid 40170204)
27. Hamdy S, Molavi O, Ma Z et al (2008) Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine 26:5046-5057
28. Healy KE, Rezania A, Stile RA (1999) Designing biomaterials to direct biological responses. Ann NY Acad Sci 875:24-35 (Pubitemid 29349059)
29. Hinrichs CS, Borman ZA, Cassard L et al (2009) Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci USA 106(41):17469-17474
30. Holger K, Frank B, Hessel E, Coffman RL (2007) Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13:552-559 (Pubitemid 46830615)
31. Hori Y, Winans AM, Huang CC et al (2008) Dendritic cell-carrying alginate gels for immunization and immunotherapy. Biomaterials 27:3671-3682
32. Hori Y, Stern PJ, Hynes RO, Irvine DJ (2009) Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy. Biomaterials 30(35):6757-6767
33. Hubbell JA, Thomas SN, Swartz MA (2009) Materials engineering for immunomodulation. Nature 462(7272):449-460
34. Huebsch N, Mooney DJ (2009) Inspiration and application in the evolution of biomaterials. Nature 462:426-432
35. Janeway CA Jr., Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216 (Pubitemid 34293424)
36. Jenne L, Arrighi JF, Jonuleit H et al (2000) Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Cancer Res 60:4446-4452 (Pubitemid 32103624)
37. Jinushi M, Hodi SF, Dranoff G (2008) Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines. Immunol Rev 222:287-298 (Pubitemid 351430380)
38. Kaiser-Schulz G, Heit A, Quintanilla-Martinez L et al (2007) Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses. J Immunol 179(5):2797-2807
39. Kallur R (2003) Angiogenesis: basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422-433
40. Kipper MJ, Wilson JH, Wannemuehler MJ, Narasimhan B (2006) Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J Biomed Mat Res 76A:798-810 (Pubitemid 47233489)
41. Klebanoff CA, Gattinoni L, Restifo NP (2006) CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211:214-224 (Pubitemid 43882974)
42. Kwon YJ, James E, Shastri N, Frechet JMJ (2005) In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci USA 102(51):18264-18268 (Pubitemid 43011215)
43. Langer R (1998) Drug delivery and targeting. Nature 392:5-10 (Pubitemid 28215187)
44. Lee KY, Rowley J, Moy E et al (2000a) Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 33:4291-4294
45. Lee KY, Peters MC, Anderson KW, Mooney DJ (2000b) Controlled growth factor release from synthetic extracellular matrices. Nature 408:998-1000 (Pubitemid 32101648)
46. Li J, Xu Z (2002) Physical characterization of a chitosan-based hydrogel delivery system. J Pharm Sci 91(7):1669-1677 (Pubitemid 34680229)
47. Li GY, Fukunaga S, Takenouch K, Nakamura F (2005) Comparative study of the physiological properties of collagen, gelatin and collagen hydrolysate as cosmetic materials. Int J Cosmet Sci 27:101-106 (Pubitemid 40445003)
48. Little SR, Lynn DM, Ge Q et al (2004) Poly-b amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci USA 101:9534-9539 (Pubitemid 38869271)
49. Lofthouse S, Nagahara S, Sedgmen B et al (2001) The application of biodegradable collagen minipellets as vaccine delivery vehicles in mice and sheep. Vaccine 19:4318-4327 (Pubitemid 32703654)
50. Majeti NV, Kuma R (2000) A review of chitin and chitosan applications. React Funct Polym 46(1):1-27
51. Manmohan S, Jina K, Mildred U et al (2005) Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 4(4):483-491
52. Marston WA, Hanft J, Norwood P et al (2003) The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26:1701
53. Mbeunkui F, Johann DJ Jr. (2009) Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 63(4):571-582
54. Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106(3):255-258 (Pubitemid 32772607)
55. Meyer M, Wagner E (2006) pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv 3:563-571 (Pubitemid 44383485)
56. Meylan E, Tschopp J, Karin M (2006) Intracellular pattern recognition receptors in the host response. Nature 442:39-44 (Pubitemid 44064203)
57. Miyata T, Taira T, Noishiki Y (1992) Collagen engineering for biomaterial use. Clin Mater 9(3-4):139-148
58. Nair RE, Jong YS, Jones SA et al (2006) IL-12 + GM-CSF microsphere therapy induces eradication of advanced spontaneous tumors in her-2/neu transgenic mice but fails to achieve longterm cure due to the inability to maintain effector T-cell activity. J Immunother 29(1):10-20
59. Napoli A, Valentini M, Tirelli N et al (2004) Oxidation-responsive polymeric vesicles. Nat Mater 3:183-189
60. Neelapu SS, Baskar S, Gause BL et al (2004) Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen. Clin Cancer Res 24:8309-8317 (Pubitemid 40053391)
61. Nemunaitis J, Jahan T, Ross H et al (2006) Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer. Cancer Gene Ther 13(6):555-562
62. Nestle FO, Alijagic S, Gillet M et al (1998) Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 4(3):328-332 (Pubitemid 28144092)
63. Nishioka Y, Yoshino H (2001) Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 47:55-64 (Pubitemid 32209232)
64. Oussoren C, Storm G (2001) Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 50:143-156 (Pubitemid 32727280)
65. Oussoren C, Zuidema J, Crommelin DJA, Storm G (1997) Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. 2. Influence of liposomal size, lipid composition and lipid dose. Biochim Biophys Acta 1328:261-272 (Pubitemid 27376453)
66. Paramonov SE, Bachelder EM, Beaudette TT (2008) Fully acid-degradable biocompatible polyacetal microparticles fordrug delivery. Bioconjug Chem 19:911-919 (Pubitemid 351614545)
67. Plautz GE, Barnett GH, Miller DW et al (1998) Systemic T cell adoptive immunotherapy of malignant gliomas. J Neurosurg 89:42-51 (Pubitemid 28285921)
68. Powell HM, Boyce ST (2006) EDC cross-linking improves skin substitute strength and stability. Biomaterials 27(34):5821-5827 (Pubitemid 44287022)
69. Reddy ST, Van Der Vlies AJ, Simeon E et al (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 2:1159-1164 (Pubitemid 47538111)
70. Rogero SO, Malmonge SM, Lugao AB et al (2003) Biocompatibility Study of Polymeric Biomaterials. Artif Organs 27(5):424-427 (Pubitemid 36570987)
71. Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10:909-915 (Pubitemid 39273730)
72. Sansonetti PJ (2006) The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 7:1237-1242 (Pubitemid 46111240)
73. Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15:138-147 (Pubitemid 36287518)
74. Silva EA, Mooney DJ (2004) Synthetic extracellular matrices for tissue engineering and regeneration. Curr Top Dev Biol 64:181-205 (Pubitemid 39752397)
75. Silva EA, Kim ES, Kong HJ, Mooney DJ (2008) Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci USA 38:14347-14352
76. Sozzani S, Allavena P, D'Amica G et al (1998) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161:1083-1086 (Pubitemid 28380531)
77. Suckow MA, Siger L, Bowersock TL et al (1999) Alginate microparticles for vaccine delivery. Polysaccharide Appl 737(1):1-14 (Pubitemid 129551505)
78. Tabata I, Ikada Y (1990) Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci 94:107-141
79. Thomasin C, Giampietro Corradin G, Men Y et al (1996) Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J Control Release 41:131-145 (Pubitemid 26246370)
80. Todd CW, Pozzi LA, Guarnaccia JR et al (1998) Development of adjuvant-active nonionic block copolymers. Adv Drug Deliv Rev 32:199-223 (Pubitemid 28267410)
81. Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-160 (Pubitemid 40282557)
82. Van Broekhoven CL, Parish CR, Demangel C et al (2004) Targeting dendritic cells with antigencontaining liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res 64:4357-4365 (Pubitemid 38802444)
83. Waeckerle-Men Y, Gander B, Groettrup M (2005) Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med 109:35-46
84. Waeckerle-Men Y, Uetz-von Allmen E, Gander B et al (2006) Encapsulation of proteins and peptides into biodegradable poly(d, l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine 24:1847-1857 (Pubitemid 43238266)
85. Wang C, Ge Q, Ting D, Nguyen D et al (2004) Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 3:190-196
86. Wischke C, Zimmermann J, Wessinger B et al (2009) Poly(I:C) coated PLGA microparticles induce dendritic cell maturation. Int J Pharm 365:61-68
87. Yoshida M, Babensee JE (2004) (2004) Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res 71A:45-51
88. Yu JS, Liu G, Ying H et al (2004) Vaccination with tumor lysate-pulsed dendritic cells elicits antigen specific cytotoxic T cells in patients with malignant glioma. Cancer Res 64:4973-4979 (Pubitemid 38924545)
89. Zaharoff DA, Hoffman BS, Hooper HB et al (2009) Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res 69:6192-6199